Responsible for assisting international clients understand the early implications of evidence for access considerations, alongside regulatory and clinical development activities, with a particular focus on proposing creative and pragmatic solutions.
Strategic and operational generation of health outcomes and real-world evidence in the context of health technology assessments (HTA) and reimbursement submissions
Patient access, pricing and reimbursement for medications, devices, and other health products, particularly for rare diseases or atypical health technologies
Extensive network of market access experts
Clinician with inpatients’ and outpatients’ care experience – 22 years of experience in healthcare
18 years of market access experience in its wide definition
Client-side experience in pharmaceutical and medical device